
    
      This is a multicenter, observational cohort trial in the real-world clinical setting
      recruiting MG patients from Neurology Departments of 6 hospitals in different regions of
      China. Clinical manifestations, laboratory test results, chest imaging and history of
      thymectomy are recorded. Patients will be classified by clinical manifestation as well as
      antibody status, and treatment regimens are determined according to the physician's judgment
      and preferences of the patients. Patients are followed up prospectively on regular to assess
      the outcomes of treatments and monitor any side effects. Peripheral blood samples are
      collected annually. Patients' clinical records are uploaded to an online database. The
      investigators plan to recruit a final sample of 2000 patients for analysis.
    
  